5 results match your criteria: "University of Paris South XI[Affiliation]"
Diabetologia
June 2007
Marie Lannelongue Hospital, UMR CNRS 8078-University of Paris South XI, 133 Avenue de la Résistance, 92350 Le Plessis Robinson, France.
Aims/hypothesis: Diabetes mellitus is a strong risk factor for the development of heart failure, and left ventricular (LV) hypertrophy has been detected in a significant proportion of diabetic patients. Because several studies have suggested that the Na(+)/H(+) exchanger (NHE1) plays a part in the molecular mechanisms involved in cardiac hypertrophy, we investigated its activity and its role in LV myocytes from the Goto-Kakizaki (GK) rat model of type 2 diabetes.
Materials And Methods: Fluorometric measurements were used to assess sarcolemmal NHE1 activity in isolated myocytes.
J Pediatr Gastroenterol Nutr
April 2007
Pediatric Hepatology and National Reference Centre for Biliary Atresia, Bicêtre Hospital, University of Paris-South XI, AP-HP, Paris, France.
Objectives: Progressive familial intrahepatic cholestasis (PFIC) and to a lesser extent, Alagille syndrome, often lead to end-stage liver disease during childhood. We report our experience of DNA-based prenatal diagnosis of PFIC1-3 and Alagille syndrome.
Patients And Methods: Four molecular antenatal diagnoses were performed in 3 PFIC families and 17 in 11 Alagille syndrome families.
Curr Top Med Chem
July 2006
Antiparasitic Chemotherapy Group, UMR 8076 CNRS, Faculty of Pharmacy, University of Paris South XI, 92290-Châtenay-Malabry, France.
The control of Leishmania infections relies primarily on chemotherapy. The arsenal of drugs available against Leishmania infections is limited and includes pentavalent antimonials, pentamidine, amphotericin B, miltefosine, paromomycin, allopurinol, and few other drugs at various stages of their development process. Knowledge about action and resistance mechanisms involved may allow the development of new drugs that minimise or circumvent drug resistance or may identify new targets for drug development.
View Article and Find Full Text PDFPharm Res
November 2003
University of Paris-South XI, Faculty of Pharmacy, UMR CNRS 8612, 5 rue Jean-Baptiste Clement, 92296 Châtenay-Malabry Cedex, France.
Purpose: The aim of this work was to synthesize new surface-modified nanoparticles using a radical emulsion polymerization of an alkyl cyanoacrylate.
Methods: Isobutyl cyanoacrylate was polymerized in nitric acid 0.2 M containing a polysaccharide (0.
Glycobiology
April 1999
INSERM U504, University of Paris South XI, 94807 Villejuif Cedex, France and CERMAV-CNRS, BP 53, 38041 Grenoble Cedex 9, France.
On the basis of function and sequence similarities, the vertebrate fucosyltransferases can be classified into three groups: alpha-2-, alpha-3-, and alpha-6-fucosyltransferases. Thirty new putative fucosyltransferase genes from invertebrates and bacteria and six conserved peptide motifs have been identified in DNA and protein databanks. Two of these motifs are specific of alpha-3-fucosyltransferases, one is specific of alpha-2-fucosyltransferases, another is specific of alpha-6-fucosyltransferases, and two are shared by both alpha-2- and alpha-6-fucosyltranserases.
View Article and Find Full Text PDF